Normalization of visceral adiposity is required to normalize plasma apolipoprotein B levels in response to a healthy eating/physical activity lifestyle modification program in viscerally obese men.

[1]  J. Després,et al.  Improvement in insulin sensitivity following a 1-year lifestyle intervention program in viscerally obese men: contribution of abdominal adiposity. , 2012, Metabolism: clinical and experimental.

[2]  Goutham Rao,et al.  Assessing adiposity: a scientific statement from the American Heart Association. , 2011, Circulation.

[3]  C. Furberg,et al.  A Meta-Analysis of Low-Density Lipoprotein Cholesterol, Non-High-Density Lipoprotein Cholesterol, and Apolipoprotein B as Markers of Cardiovascular Risk , 2011, Circulation. Cardiovascular quality and outcomes.

[4]  J. Kastelein,et al.  Lipid parameters for measuring risk of cardiovascular disease , 2011, Nature Reviews Cardiology.

[5]  R. Ross,et al.  Position Statement Identification and Management of Cardiometabolic Risk in Canada: A Position Paper by the Cardiometabolic Risk Working Group (Executive Summary) , 2011 .

[6]  J. Després,et al.  Cardiometabolic effects of rosiglitazone in patients with type 2 diabetes and coronary artery bypass grafts: A randomized placebo-controlled clinical trial. , 2010, Atherosclerosis.

[7]  R. Ross,et al.  Effect of Rimonabant on the High-Triglyceride/Low–HDL-Cholesterol Dyslipidemia, Intraabdominal Adiposity, and Liver Fat: The ADAGIO-Lipids Trial , 2009, Arteriosclerosis, thrombosis, and vascular biology.

[8]  H. Toplak,et al.  Treatment Modalities of Obesity , 2008, Diabetes Care.

[9]  S. Anderssen,et al.  ApoB but not LDL‐cholesterol is reduced by exercise training in overweight healthy men. Results from the 1‐year randomized Oslo Diet and Exercise Study , 2007, Journal of internal medicine.

[10]  H. Ginsberg,et al.  Metabolic Syndrome: Focus on Dyslipidemia , 2006, Obesity.

[11]  A M Nevill,et al.  Cardiovascular disease risk factors in habitual exercisers, lean sedentary men and abdominally obese sedentary men , 2005, International Journal of Obesity.

[12]  B. Howard,et al.  Obesity and dyslipidemia. , 2003, Endocrinology and metabolism clinics of North America.

[13]  A. Sherwood,et al.  Effects of exercise and weight loss on cardiac risk factors associated with syndrome X. , 2003, Archives of internal medicine.

[14]  M. Mozzoli,et al.  FFA cause hepatic insulin resistance by inhibiting insulin suppression of glycogenolysis. , 2002, American journal of physiology. Endocrinology and metabolism.

[15]  A. Keech,et al.  Relationship Between Lipid Levels and Clinical Outcomes in the Long-Term Intervention With Pravastatin in Ischemic Disease (LIPID) Trial: To What Extent Is the Reduction in Coronary Events With Pravastatin Explained by On-Study Lipid Levels? , 2002, Circulation.

[16]  Robert Ross,et al.  Abdominal adiposity and insulin resistance in obese men. , 2002, American journal of physiology. Endocrinology and metabolism.

[17]  A. Sniderman,et al.  Hypertriglyceridemic HyperapoB: The Unappreciated Atherogenic Dyslipoproteinemia in Type 2 Diabetes Mellitus , 2001, Annals of Internal Medicine.

[18]  Robert Ross,et al.  Reduction in Obesity and Related Comorbid Conditions after Diet-Induced Weight Loss or Exercise-Induced Weight Loss in Men , 2000, Annals of Internal Medicine.

[19]  D. Gaudet,et al.  Hypertriglyceridemic waist: A marker of the atherogenic metabolic triad (hyperinsulinemia; hyperapolipoprotein B; small, dense LDL) in men? , 2000, Circulation.

[20]  G. Watts,et al.  Reduction in visceral adipose tissue is associated with improvement in apolipoprotein B-100 metabolism in obese men. , 1999, The Journal of clinical endocrinology and metabolism.

[21]  F. Riches,et al.  Hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 studied with a stable isotope technique in men with visceral obesity , 1998, International Journal of Obesity.

[22]  G. Thorgeirsson,et al.  Lipoprotein changes and reduction in the incidence of major coronary heart disease events in the Scandinavian Simvastatin Survival Study (4S) , 1998, Circulation.

[23]  P. Arner.  Regional adipocity in man. , 1997, The Journal of endocrinology.

[24]  G. Dagenais,et al.  Apolipoprotein A-I and B levels and the risk of ischemic heart disease during a five-year follow-up of men in the Québec cardiovascular study. , 1996, Circulation.

[25]  G. Watts,et al.  Acute hyperinsulinaemia decreases cholesterol synthesis less in subjects with non‐insulin‐dependent diabetes mellitus than in non‐diabetic subjects , 1996, European journal of clinical investigation.

[26]  S. Haffner.  Risk factors for non-insulin-dependent diabetes mellitus , 1995, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[27]  M. Visser,et al.  Abdominal diameters as indicators of visceral fat: comparison between magnetic resonance imaging and anthropometry , 1993, British Journal of Nutrition.

[28]  K. Cianflone,et al.  Substrate delivery as a determinant of hepatic apoB secretion. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.

[29]  J. Després,et al.  Effects of Diet and Physical Activity on Adiposity and Body Fat Distribution: Implications for the Prevention of Cardiovascular Disease , 1993, Nutrition Research Reviews.

[30]  C. Bouchard,et al.  Assessment of adipose tissue distribution by computed axial tomography in obese women: association with body density and anthropometric measurements , 1989, British Journal of Nutrition.

[31]  R. Turner,et al.  Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man , 1985, Diabetologia.

[32]  L. Prencipe,et al.  Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide. , 1982, Clinical chemistry.

[33]  G. Borkan,et al.  Assessment of abdominal fat content by computed tomography. , 1982, The American journal of clinical nutrition.

[34]  P. Fu,et al.  Enzymatic determination of total serum cholesterol. , 1974, Clinical chemistry.

[35]  L H Kuller,et al.  Japanese men have larger areas of visceral adipose tissue than Caucasian men in the same levels of waist circumference in a population-based study , 2012, International Journal of Obesity.

[36]  Salim Yusuf,et al.  Prognostic impact of body weight and abdominal obesity in women and men with cardiovascular disease. , 2005, American heart journal.

[37]  S. Heymsfield,et al.  Comparison of visceral adipose tissue mass in adult African Americans and whites. , 2005, Obesity research.